Structural factors -- an untapped, yet vital part of HIV prevention

August 05, 2008

In order to successfully prevent as many HIV infections as possible, attention must be given to structural factors that affect vulnerability and risk, as well as focusing on individual level behaviours. These are the conclusions of Dr Geeta Rao Gupta and Dr Jessica Ogden, International Center for Research on Women (ICRW), Washington, DC, USA, and colleagues, authors of the fourth paper in The Lancet Series on HIV Prevention.

Structural factors are defined as physical, social, cultural, organisational, community, economic, or legal aspects of the environment that impede or facilitate efforts to avoid HIV infection. Studies have shown a meaningful association between structural factors and HIV risk. Examples of such factors include income and relative wealth, gender inequality, exposure to domestic violence, school enrolment, and being orphaned. All of these things provide a guide to the vulnerability of an individual that increases their risk of HIV exposure or limits their ability to protect themselves from infection. Structural approaches can include policies and/or programmes that aim to change the conditions in which and under which people live.

There are several examples of HIV and AIDS initiatives that have taken a structural approach. The Sonagachi project - a community oriented project addressing the needs of Indian sex workers - reduced HIV prevalence to 10%, compared with 50-90% in many Indian cities. An essential component of its success was that the sex workers themselves were empowered to decide what they needed to do and to take action. Condom use rose from 3% to 90% during the programme's implementation in the 1990s. Needle exchange programmes for injecting drug users are also examples of structural approaches, as they require a shift in policy in the contexts where such possession or use of such drugs is illegal. Such policy shifts remain a challenge for many nations, yet evidence shows that needle exchange programmes reduce HIV infection in injecting drug users without adverse effects.

Gender inequality is another structural factor that affects vulnerability to HIV. For example, women's unequal access to paid work can contribute to their economic dependence on men, which can make it difficult for a woman to negotiate condom use. Structural approaches to lessen gender inequality and vulnerability to HIV could include increasing women's access to credit and other financial services that make them more economically independent.

The authors stress the importance of understanding the social and epidemiological context in which a structural approach is to be taken, and argue that: "When implementing a structural approach, there is no single blueprint that will work everywhere." They add, however, that structural programmes applied in one setting can be implemented in another through careful adaptation based on critical features of the new setting. The authors also acknowledge the difficulties in assessing structural approaches due to their indirect effect on HIV transmission, and the fact that they can often involve multiple activities. They emphasise that the randomised trial is not always the best method for assessment of structural approaches, due to the complexity and often layered nature of structural approaches. They call for closer collaboration between groups implementing the structural changes, eg, community groups, and social science experts who have the skills to effectively monitor effects of the intervention.

The authors conclude: "Sustained progress in HIV prevention requires structural approaches rather than continuing to address individual-level factors. Structural factors can be influenced but until they are, individuals in many settings will find it difficult to reduce their risk and vulnerability...Structural approaches represent a largely untapped, yet crucial, part of combination HIV prevention advocated for in this Series. Serious attention must be given to defining and building capacity to make that happen."
-end-
Dr Geeta Rao Gupta, International Center for Research on Women (ICRW), Washington, DC, USA T) +1 202 797 0007 ext. 166 E) geeta@icrw.org

Dr Jessica Ogden, International Center for Research on Women (ICRW), Washington, DC, USA (attending conference) (cell) T) +1 571 271 9749 E) jogden-consultant@icrw.org

Please note: a press conference to launch this series will take place at the International AIDS conference on Tuesday 5 August, 1500-1545 (Mexico City time) in Room 1 (Aztecas), Media Centre, Hall A, Level 1, Centro Banamex, Mexico City

http://multimedia.thelancet.com/pdf/press/hiv4.pdf

http://multimedia.thelancet.com/pdf/press/hivcomment.pdf

Lancet

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.